Hepatitis c and Interstitial lung disease - from FDA reports

Summary

Interstitial lung disease is found among people with Hepatitis c, especially for people who are male, 60+ old, take medication Rebetol and have High blood pressure. This review analyzes which people have Interstitial lung disease with Hepatitis c. It is created by eHealthMe based on reports of 288 people who have Hepatitis c from FDA , and is updated regularly.

What to expect?

If you have Hepatitis c and Interstitial lung disease, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Hepatitis c and Interstitial lung disease

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 21, 2017

288 people who have Hepatitis C and Interstitial Lung Disease are studied.


Number of reports submitted per year:

Would you have Interstitial lung disease when you have Hepatitis c?

Gender of people who have Hepatitis C and experience Interstitial Lung Disease *:

  • female: 37.64 %
  • male: 62.36 %

Age of people who have Hepatitis C and experience Interstitial Lung Disease *:

  • 0-1: 0.4 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.98 %
  • 40-49: 10.71 %
  • 50-59: 29.76 %
  • 60+: 57.14 %

Top co-existing conditions for these people *:

  • High Blood Pressure (19 people, 6.60%)
  • Preventive Health Care (11 people, 3.82%)
  • Depression (7 people, 2.43%)
  • Prostate Cancer (6 people, 2.08%)
  • Hyperuricaemia (6 people, 2.08%)

Most common drugs for these people *:

  • Rebetol (103 people, 35.76%)
  • Pegasys (74 people, 25.69%)
  • Peg-Intron (65 people, 22.57%)
  • Ribavirin (61 people, 21.18%)
  • Copegus (31 people, 10.76%)

Top symptoms for these people *:

  • Fever (35 people, 12.15%)
  • Thrombocytopenia (28 people, 9.72%)
  • Cough (27 people, 9.38%)
  • Anaemia (27 people, 9.38%)
  • Breathing Difficulty (22 people, 7.64%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Interstitial lung disease and Hepatitis c?

Expand the study to include reports from both FDA and eHealthMe

Interstitial lung disease and Hepatitis c from FDA and eHealthMe reports

Hepatitis C

Hepatitis c can be treated by Ribavirin, Pegasys, Peginterferon, Incivek, Pegintron (latest reports from 106,193 Hepatitis c patients)

Interstitial Lung Disease

Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, preventive health care, lung cancer - non-small cell, breast cancer (latest reports from 30,952 Interstitial lung disease patients).

Browse all symptoms of Hepatitis c

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Interstitial lung disease

Interstitial lung disease

Other conditions that could case Interstitial lung disease

Interstitial lung disease

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Hepatitis c and Interstitial lung disease.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >